RxDoctor Payments Data

Emily Lanier, DO

Family Medicine · Morehead City, NCNPI 1659952646

Payments from drug & device makers

$1,117in general payments, 2019–2025

Across 31 payments — averaging $36.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$288
  • Novo Nordisk$234
  • AbbVie$168
  • Amgen$156
  • Phathom Pharmaceuticals, Inc.$119
  • GSK$36
  • plus $116 from 5 others

What the payments were for

  • Food & beverage$1,117100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,117 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$55,118
Medicare patients
266
Services billed
685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$21,248
OzempicSemaglutide18$16,926
EliquisApixaban11$9,286
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,531
Albuterol Sulfate HfaAlbuterol Sulfate36$998
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$963
Rosuvastatin Calcium27$654
Amlodipine Besylate101$624
Omeprazole32$604
Fluticasone Propionate39$591
Atorvastatin Calcium74$480
Chlorthalidone20$433
Metoprolol Succinate39$355
Lisinopril42$300
Bupropion XlBupropion Hcl13$300

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$234$16,92618 claims
GSKTrelegy Ellipta$36$8,53113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Morehead City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →